Comparison of inflammatory cytokine levels among type I/type II and manic/hypomanic/euthymic/depressive states of bipolar disorder

Journal of Affective Disorders

Volumn 166, Issue , 2014, Pages 187-192

  Bai, Ya Mei ^a,b   Su, Tung Ping ^a,b   Tsai, Shih Jen ^a,b   Wen Fei, Chiou ^b,c,d   Li, Cheng Ta ^a,b   Pei Chi, Tu ^a,b   Mu Hong, Chen ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

^d NATIONAL TAITUNG UNIVERSITY   (Taiwan)

Author keywords

Bipolar disorder; Inflammatory cytokines

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; C REACTIVE PROTEIN; CARBAMAZEPINE; CYTOKINE; INTERLEUKIN 6 RECEPTOR; LAMOTRIGINE; LITHIUM SULFATE; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; SOLUBLE INTERLEUKIN 2 RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; VALPROIC ACID; BIOLOGICAL MARKER; INTERLEUKIN 2 RECEPTOR; TNFRSF1A PROTEIN, HUMAN;

ADULT; AGE; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BIPOLAR MANIA; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS REACTION; DISEASE DURATION; EDUCATIONAL STATUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING; AGED; BIPOLAR DISORDER; BLOOD; CASE CONTROL STUDY; INFLAMMATION; METABOLISM; MIDDLE AGED; OUTPATIENT; PSYCHOLOGY;

ADULT; AGED; BIOLOGICAL MARKERS; BIPOLAR DISORDER; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; OUTPATIENTS; P-SELECTIN; RECEPTORS, INTERLEUKIN-2; RECEPTORS, INTERLEUKIN-6; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I;

EID: 84902113020     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2014.05.009     Document Type: Article

References (51)

1. A.C. Altamura, and E. Mundo et al. The MCP-1 gene (SCYA2) and mood disorders: preliminary results of a case-control association study Neuroimmunomodulation 17 2 2010 126 131
2. I.G. Barbosa, and R.B. Huguet et al. Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder Eur. Arch. Psychiatry Clin. Neurosci. 261 2 2011 139 143
3. I.G. Barbosa, and C.R. Nogueira et al. Altered intracellular signaling cascades in peripheral blood mononuclear cells from BD patients J. Psychiatr. Res. 47 12 2013 1949 1954
4. I.G. Barbosa, and N.P. Rocha et al. Increased levels of adipokines in bipolar disorder J. Psychiatr. Res. 46 3 2012 389 393
5. I.G. Barbosa, and N.P. Rocha et al. Executive dysfunction in euthymic bipolar disorder patients and its association with plasma biomarkers J. Affective Disord. 137 1-3 2012 151 155
6. E. Brietzke, and L. Stertz et al. Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder J. Affective Disord. 116 3 2009 214 217
7. E. Brietzke, and A.L. Teixeira Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor Bipolar Disord. 12 4 2010 453 454
8. T. Cetin, and S. Guloksuz et al. Plasma concentrations of soluble cytokine receptors in euthymic bipolar patients with and without subsyndromal symptoms BMC Psychiatry 12 2012 158
9. M.H. Chen, and T.P. Su et al. Higher risk of developing major depression and bipolar disorder in later life among adolescents with asthma: a nationwide prospective study J. Psychiatr. Res. 2013
10. D. De Berardis, and C.M. Conti et al. Evaluation of C-reactive protein and total serum cholesterol in adult patients with bipolar disorder Int. J. Immunopathol. Pharmacol. 21 2 2008 319 324
11. F. Dickerson, and C. Stallings et al. Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder Prog. Neuropsychopharmacol. Biol. Psychiatry 31 4 2007 952 955
12. O. Frank, and M. Giehl et al. Human endogenous retrovirus expression profiles in samples from brains of patients with schizophrenia and bipolar disorders J. Virol. 79 17 2005 10890 10901
13. B.I. Goldstein, and D.E. Kemp et al. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature J. Clin. Psychiatry 70 8 2009 1078 1090
14. S. Guloksuz, and K. Altinbas et al. Evidence for an association between tumor necrosis factor-alpha levels and lithium response J. Affective Disord. 143 1-3 2012 148 152
15. S. Guloksuz, and E.A. Cetin et al. Cytokine levels in euthymic bipolar patients J. Affective Disord. 126 3 2010 458 462
16. B. Gustafson Adipose tissue, inflammation and atherosclerosis J. Atheroscler. Thromb. 17 4 2010 332 341
17. N. Hamdani, and R. Tamouza et al. Immuno-inflammatory markers of bipolar disorder: a review of evidence Front. Biosci. (Elite Ed.) 4 2012 2170 2182
18. C.J. Hawley, and T.M. Gale et al. Defining remission by cut off score on the MADRS: selecting the optimal value J. Affective Disord. 72 2 2002 177 184
19. S. Hope, and I. Dieset et al. Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia J. Psychiatr. Res. 45 12 2011 1608 1616
20. K.A. Jones, and C. Thomsen. The role of the innate immune system in psychiatric disorders Mol. Cell. Neurosci. 53 2013 52 62
21. F. Kapczinski, and F. Dal-Pizzol et al. Peripheral biomarkers and illness activity in bipolar disorder J. Psychiatr. Res. 45 2 2011 156 161
22. Y.K. Kim, and H.G. Jung et al. Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder J. Affective Disord. 104 1-3 2007 91 95
23. Y.K. Kim, and A.M. Myint et al. T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients Psychiatry Res. 129 3 2004 267 272
24. Y.K. Kim, and I.B. Suh et al. The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs Mol. Psychiatry 7 10 2002 1107 1114
25. M. Kunz, and K.M. Cereser et al. Serum levels of IL-6, IL-10 and TNF-alpha in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance Rev. Bras. Psiquiatr. 33 3 2011 268 274
26. M. Leboyer, and I. Soreca et al. Can bipolar disorder be viewed as a multi-system inflammatory disease? J. Affective Disord. 141 1 2012 1 10
27. S.Y. Lee, and S.L. Chen et al. Inflammations association with metabolic profiles before and after a twelve-week clinical trial in drug-naive patients with bipolar II disorder PLoS One 8 6 2013 e66847
28. M. Lukasiewicz, and S. Gerard et al. Young Mania Rating Scale: how to interpret the numbers? Determination of a severity threshold and of the minimal clinically significant difference in the EMBLEM cohort Int. J. Methods Psychiatr. Res. 22 1 2013 46 58
29. M. Maes Evidence for an immune response in major depression: a review and hypothesis Prog. Neuropsychopharmacol. Biol. Psychiatry 19 1 1995 11 38
30. R.K. McNamara, and F.E. Lotrich. Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target? Expert Rev. Neurother. 12 9 2012 1143 1161
31. A. Modabbernia, and S. Taslimi et al. Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies Biol. Psychiatry 74 1 2013 15 25
32. K. Munkholm, and J.V. Brauner et al. Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis J. Psychiatr. Res. 47 9 2013 1119 1133
33. K. Munkholm, and M. Vinberg et al. Cytokines in bipolar disorder: a systematic review and meta-analysis J. Affective Disord. 144 1-2 2013 16 27
34. S.M. O'Brien, and P. Scully et al. Cytokine profiles in bipolar affective disorder: focus on acutely ill patients J. Affective Disord. 90 2-3 2006 263 267
35. A. Ortiz-Dominguez, and M.E. Hernandez et al. Immune variations in bipolar disorder: phasic differences Bipolar Disord. 9 6 2007 596 602
36. C.U. Pae, and J.J. Kim et al. Monocyte chemoattractant protein-1 promoter -2518 polymorphism may have an influence on clinical heterogeneity of bipolar I disorder in the Korean population Neuropsychobiology 49 3 2004 111 114
37. C.L. Raison, and L. Capuron et al. Cytokines sing the blues: inflammation and the pathogenesis of depression Trends Immunol. 27 1 2006 24 31
38. M.H. Rapaport, and L. Guylai et al. Immune parameters in rapid cycling bipolar patients before and after lithium treatment J. Psychiatr. Res. 33 4 1999 335 340
39. A. Remlinger-Molenda, and P. Wojciak et al. Selected cytokine profiles during remission in bipolar patients Neuropsychobiology 66 3 2012 193 198
40. B. Rossi, and S. Angiari et al. Vascular inflammation in central nervous system diseases: adhesion receptors controlling leukocyte-endothelial interactions J. Leukocyte Biol. 89 4 2011 539 556
41. J.K. Soczynska, and S.H. Kennedy et al. The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: novel hypothesis-driven treatments for bipolar depression? Neurotoxicology 30 4 2009 497 521
42. L. Stertz, and P.V. Magalhaes et al. Is bipolar disorder an inflammatory condition? The relevance of microglial activation Curr. Opin. Psychiatry 26 1 2013 19 26
43. A. Szlagatys-Sidorkiewicz, and E. Wos et al. Cytokine profile of mature milk from smoking and nonsmoking mothers J. Pediatr. Gastroenterol. Nutr. 56 4 2013 382 384
44. M. Szulinska, and T. Piorunek et al. Evaluation of insulin resistance, tumor necrosis factor alpha, and total antioxidant status in obese patients smoking cigarettes Eur. Rev. Med. Pharmacol. Sci. 17 14 2013 1916 1922
45. M. Tohen, and E. Frank et al. The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders Bipolar Disord. 11 5 2009 453 473
46. S.Y. Tsai, and K.P. Chen et al. Activation of indices of cell-mediated immunity in bipolar mania Biol. Psychiatry 45 8 1999 989 994
47. S.Y. Tsai, and K.H. Chung et al. Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder J. Affective Disord. 136 1-2 2012 110 116
48. S.Y. Tsai, and Y.Y. Yang et al. Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania J. Affective Disord. 64 2-3 2001 185 193
49. C. Viedt, and R. Dechend et al. MCP-1 induces inflammatory activation of human tubular epithelial cells: involvement of the transcription factors, nuclear factor-kappaB and activating protein-1 J. Am. Soc. Nephrol. 13 6 2002 1534 1547
50. P.H. Wirtz, and S. Hong et al. Depressive symptoms are associated with soluble P-selectin reactivity to acute exercise in heart failure Biol. Psychiatry 65 9 2009 801 807
51. A. Yarlagadda, and E. Alfson et al. The blood brain barrier and the role of cytokines in neuropsychiatry Psychiatry (Edgmont) 6 11 2009 18 22